MedTrace Logo

Determining the Efficacy of Essential Oil Aromatherapy in Children Undergoing Port Access

NCT05696899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-12-13

No results posted yet for this study

Summary

The purpose of this study is to determine if the use of aromatherapy impacts patient anxiety and pain scores surrounding port access in pediatric oncology patients between the ages of 4 years and 18 years.

Conditions

  • Anxiety and Fear
  • Pain

Interventions

OTHER

STILL QuickTAB Medipack blended scent aromatherapy, manufactured by Soothing Scents

A resealable quick-tab dispenser with the 'therapeutic inhaled essential oils' lavender, bergamot, sweet orange, and ylang ylang.

Sponsors & Collaborators

Principal Investigators

  • Annette Nasr, PhD · Stanford University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-05
Primary Completion
2024-05-30
Completion
2024-05-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05696899 on ClinicalTrials.gov